Literature DB >> 20512456

Life-threatening cardiac manifestations of primary antiphospholipid syndrome.

Rafal Grzybczak1, Anetta Undas, Pawel Rostoff, Andrzej Gackowski, Urszula Czubek, Katarzyna Stopyra, Wieslawa Piwowarska.   

Abstract

We report a rare case of primary antiphospholipid syndrome (APS) in a 43-year-old man presenting as recurrent acute coronary stent thrombosis and complicated by three myocardial infarctions. As illustrated in this report, in APS patients recurrent life-threatening arterial thrombotic events may occur in spite of recommended anticoagulant therapy. We conclude that the APS should be considered as a potential cause of acute coronary syndrome, particularly in young individuals with a history of recurrent thrombotic events and/or with abnormal coagulation test results. Further studies are needed to determine the best therapeutic strategy for APS patients with acute coronary syndrome.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20512456     DOI: 10.1007/s00380-009-1193-7

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  17 in total

1.  Moderate dose oral anticoagulant therapy in patients with the antiphospholipid syndrome? Yes.

Authors:  M-F Scully
Journal:  J Thromb Haemost       Date:  2005-05       Impact factor: 5.824

2.  International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).

Authors:  S Miyakis; M D Lockshin; T Atsumi; D W Branch; R L Brey; R Cervera; R H W M Derksen; P G DE Groot; T Koike; P L Meroni; G Reber; Y Shoenfeld; A Tincani; P G Vlachoyiannopoulos; S A Krilis
Journal:  J Thromb Haemost       Date:  2006-02       Impact factor: 5.824

3.  Impact of post-dilatation with a focal expanding balloon for optimization of intracoronary stenting.

Authors:  Fumiaki Mori; Yukio Tsurumi; Nobuhisa Hagiwara; Hiroshi Kasanuki
Journal:  Heart Vessels       Date:  2007-05-21       Impact factor: 2.037

Review 4.  Antiphospholipid-thrombosis syndromes.

Authors:  R L Bick; B Arun; E P Frenkel
Journal:  Haemostasis       Date:  1999

Review 5.  Anticoagulation strategies for treatment of ischemic stroke and antiphospholipid syndrome: case report and review of the literature.

Authors:  Shawnna L Patterson; Marian P LaMonte; Jamal A Mikdashi; Stuart T Haines; Marcie J Hursting
Journal:  Pharmacotherapy       Date:  2006-10       Impact factor: 4.705

Review 6.  Valvular dysfunction in antiphospholipid syndrome: prevalence, clinical features, and treatment.

Authors:  G Nesher; J Ilany; D Rosenmann; A S Abraham
Journal:  Semin Arthritis Rheum       Date:  1997-08       Impact factor: 5.532

Review 7.  New targeted therapies for treatment of thrombosis in antiphospholipid syndrome.

Authors:  Silvia S Pierangeli; Mariano E Vega-Ostertag; Emilio B González
Journal:  Expert Rev Mol Med       Date:  2007-11-13       Impact factor: 5.600

8.  Anti-cardiolipin antibodies and risk of myocardial infarction in a prospective cohort of middle-aged men.

Authors:  O Vaarala; M Mänttäri; V Manninen; L Tenkanen; M Puurunen; K Aho; T Palosuo
Journal:  Circulation       Date:  1995-01-01       Impact factor: 29.690

9.  Valvular heart disease in the primary antiphospholipid syndrome.

Authors:  E Galve; J Ordi; J Barquinero; A Evangelista; M Vilardell; J Soler-Soler
Journal:  Ann Intern Med       Date:  1992-02-15       Impact factor: 25.391

10.  Enhanced expression of TLR4 in smooth muscle cells in human atherosclerotic coronary arteries.

Authors:  Kazunori Otsui; Nobutaka Inoue; Seiichi Kobayashi; Rio Shiraki; Tomoyuki Honjo; Motonori Takahashi; Ken-Ichi Hirata; Seinosuke Kawashima; Mitsuhiro Yokoyama
Journal:  Heart Vessels       Date:  2007-11-26       Impact factor: 2.037

View more
  3 in total

1.  Primary percutaneous coronary intervention and intravascular ultrasound imaging for coronary thrombosis after cisplatin-based chemotherapy.

Authors:  Daisuke Ito; Jun Shiraishi; Takeshi Nakamura; Naoki Maruyama; Yumi Iwamura; Sho Hashimoto; Masayoshi Kimura; Akihiro Matsui; Hirokazu Yokoi; Masayasu Arihara; Hidekazu Irie; Masayuki Hyogo; Takatomo Shima; Yoshio Kohno; Akiyoshi Matsumuro; Takahisa Sawada; Hiroaki Matsubara
Journal:  Heart Vessels       Date:  2012-01-05       Impact factor: 2.037

2.  Antiphospholipid syndrome combined with acute coronary syndrome: Case report.

Authors:  Yuan Shan; Ping Wang; JingHua Liu
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.889

3.  Intravascular Images of Coronary Stenosis with Multiple Channels in a Patient with Antiphospholipid Syndrome: The Optical Coherence Tomography Findings.

Authors:  Shigenori Ito; Takahiro Hasuo
Journal:  Intern Med       Date:  2017-06-01       Impact factor: 1.271

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.